Equine Cushing’s Drug Pergolide to be Withdrawn for Human Use
The FDA has announced pergolide is to be voluntarily withdrawn for human use. Pergolide is commonly used for horses with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease.
According to the FDA announcement
- Topics: Article, Cushing's Disease
Share
ADVERTISEMENT
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Share
Erin Ryder is a former news editor of The Horse: Your Guide To Equine Health Care.
Related Articles
Stay on top of the most recent Horse Health news with
